Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T1GG
|
|||
| Drug Name |
3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivative 1
|
|||
| Synonyms |
PMID28621580-Compound-WO2013101954c67
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Blood vessel proliferative disorder [ICD-11: BE2Z] | Patented | [1] | |
| Cell proliferative disorder [ICD-11: FB86] | Patented | [1] | ||
| Metabolic disorder [ICD-11: 5C50-5D2Z; ICD-10: IV] | Patented | [1] | ||
| Company |
ALLERGAN, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Sep;27(9):987-1004. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.